Healthcare & Life Sciences
Esker Therapeutics
United Stateseskertx.com
Esker Therapeutics is a series a startup based in United States. 1 investor tracked.
Activeseries-a
series-a
Stage
2018
Founded
1
Investors
About Esker Therapeutics
Based in the United States, Esker Therapeutics is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Esker Therapeutics was a biotechnology company that developed precision medicines for autoimmune diseases, with an initial focus on psoriasis. The company was acquired by Eli Lilly in 2021.
Explore Esker Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.